Cogstate Limited (COGZF) Q2 2025 Earnings Call Transcript
Q2 2025 Earnings Conference Call February 19, 2025 5:00 PM ET. Company Participants. Brad O'Connor - Chief Executive Officer Darren Watson - Chief F ...
Cogstate signals strong H2 2025 revenue potential with $16.3M contracted pipeline
Brad O'Connor, CEO, highlighted the company’s record revenue of $23.9 million for the first half of FY 2025, driven by a 27% growth in clinical trials revenue compared to the prior corresponding ...
'Health equity is a business imperative:' Companies work for better Black health outcomes
At the State of Black Health second annual summit hosted by BlackDoctor.org in partnership with USA TODAY, corporate leaders ...
Pharmabiz3d
Eisai announces Leqembi sales reaches €200 million; BioArctic to receive €10 million payment
Eisai announces Leqembi sales reaches €200 million; BioArctic to receive €10 million payment: Stockholm, Sweden Wednesday, February 19, 2025, 14:00 Hrs [IST] BioArctic AB’s ...
Medivir AB: Year-End Report January - December 2024
"We are now, within short, ready to initiate the phase 2b study - with the goal of making fostrox + Lenvima the first approved medical treatment for second-line liver cancer" October - DecemberFinanci ...
BioArctic: Leqembi sales reaches €200 million - first sales milestone achieved
BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai has notified BioArctic that the first sales milestone according to the licensing agreement ...
Le Lézard4d
Leqembi® sales reaches ?200 million - first sales milestone achieved
BioArctic AB's (publ) partner Eisai has notified BioArctic that the first sales milestone according to the licensing agreement has been reached. The milestone was reached as sales of Leqembi reached ?